Suchergebnisse - "Norton, Elizabeth B."

PubPharm (6)

1

The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT

enthalten in: mSphere | 2018

von Clements, J. | Norton, E.

2

Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)

enthalten in: PloS one | 2015

von Norton, E. | Branco, L. | Clements, J.

ErratumIn: PLoS One. 2015;10(9):e0138938. - PMID 26383114

3

Simultaneous exposure to Escherichia coli heat-labile and heat-stable enterotoxins increases fluid secretion and alters cyclic nucleotide and cytokine production by intestinal epithelial cells

enthalten in: Infection and immunity | 2014

von Read, L. | Hahn, R. | Thompson, C. | +3

4

The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens

enthalten in: Infection and immunity | 2012

von Norton, E. | Lawson, L. | Mahdi, Z. | +2

5

Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant

enthalten in: Clinical and vaccine immunology : CVI | 2011

von Norton, E. | Lawson, L. | Freytag, L. | +1

6

Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model

enthalten in: Journal of virology | 2010

von Norton, E. | Clements, J. | Voss, T. | +1

1
[1]